Company: OPGN
Filing Date: 2025-10-31
Form Type: 10-Q
Source: 0001829126-25-008771
Chunk: 35

Company: OPGEN INC
Filing Date: 2025-10-31
Form: 10-Q
Item: Part I, Item 1
Chunk 35
---
 from CapForce’s listing sponsorship and consulting services, and we anticipate generating revenues
from CapForce’s other business ventures including cross-border securities trading, advanced computational model-enabled investment
banking advisory and asset management services, and FinTech-enabled capital table management solutions via CapForce’s next generation
global digital investment banking platform.

Cost
of Products, Cost of Services, and Operating Expenses

Prior
to the repositioning of our business, our cost of products consisted of product and inventory costs, including materials costs and overhead,
and other costs related to the recognition of revenue. Cost of services related to the material and labor costs associated with providing
our services. Research and development expenses consisted primarily of expenses incurred in connection with our clinical and pre-clinical
research activities. Selling, general and administrative expenses consisted of public company costs, salaries, and related costs for administrative,
sales, and business development personnel.

Following
the acquisition of a controlling interest in the Company by AEI Capital Ltd. and the formation of CapForce as OpGen’s wholly-owned
subsidiary, the Company’s cost of sales will primarily be subcontractor and advisor fees and technology infrastructure costs associated
with providing our services. Research and development expenses consist of fees to expand and innovate CapForce’s digital investment
banking platform, and selling, general, and administrative expenses continue to consist of public company costs, salaries, and related
costs for administrative and business development purposes.

24

Results
of operations for the three months ended June 30, 2025 and 2024

Revenues

    Three Months Ended
        June 30,

    2025

    2024

    Product sales
     
    $
    -

    $
    28,000

    Laboratory services

    -

    -

    Listing sponsorship services

    4,000,000

    -

    Total revenue
     
    $
    4,000,000

    $
    28,000

We recognized revenue in the three months ended June 30, 2025 solely
related to our single contract to provide listing sponsorship and consulting services, as CapForce completed the second performance obligation
within the Engagement Agreement, earning proceeds of $4.0 million in the Client’s equity. 

Operating
expenses

    Three Months Ended
        June 30,

    2025

    2024

    Cost of products sold
     
    $
    -

    $
    (41,600
    )
  
    Cost